Literature DB >> 27747056

Risk guided use of the direct thrombin inhibitor bivalirudin: insights from recent trials and analyses.

William B Hillegass1, Gregory S Bradford1.   

Abstract

Entities:  

Year:  2016        PMID： 27747056      PMCID： PMC5059288          DOI： 10.21037/jtd.2016.08.79

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  48 in total

1.  Comparison of heparin and bivalirudin in patients undergoing percutaneous coronary intervention without use of glycoprotein IIb/IIIa inhibitors.

Authors:  Farhad Abtahian; Stephen Waldo; Ik-Kyung Jang
Journal:  Catheter Cardiovasc Interv       Date:  2015-03-30       Impact factor: 2.692

Review 2.  Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.

Authors:  Faiez Zannad; Wendy Gattis Stough; Véronique Regnault; Mihai Gheorghiade; Efthymios Deliargyris; C Michael Gibson; Stefan Agewall; Scott D Berkowitz; Paul Burton; Gonzalo Calvo; Sidney Goldstein; Freek W A Verheugt; Joerg Koglin; Christopher M O'Connor
Journal:  Int J Cardiol       Date:  2013-01-06       Impact factor: 4.164

3.  Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Authors:  Yaling Han; Jincheng Guo; Yang Zheng; Hongyun Zang; Xi Su; Yu Wang; Shaoliang Chen; Tiemin Jiang; Ping Yang; Jiyan Chen; Dongju Jiang; Quanmin Jing; Zhenyang Liang; Haiwei Liu; Xin Zhao; Jing Li; Yi Li; Bo Xu; Gregg W Stone
Journal:  JAMA       Date:  2015-04-07       Impact factor: 56.272

4.  Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography).

Authors:  Peter Clemmensen; Sebastian Wiberg; Arnoud Van't Hof; Efthymios N Deliargyris; Pierre Coste; Jurrien Ten Berg; Claudio Cavallini; Martial Hamon; Dariusz Dudek; Uwe Zeymer; Xavier Tabone; Steen D Kristensen; Debra Bernstein; Prodromos Anthopoulos; Jayne Prats; Philippe Gabriel Steg
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

5.  Bivalirudin versus heparin in patients with acute myocardial infarction: A meta-analysis of randomized trials.

Authors:  Giuseppe Ferrante; Marco Valgimigli; Paolo Pagnotta; Patrizia Presbitero
Journal:  Catheter Cardiovasc Interv       Date:  2015-04-24       Impact factor: 2.692

Review 6.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

7.  Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

Authors:  M Moscucci; K A A Fox; Christopher P Cannon; W Klein; José López-Sendón; G Montalescot; K White; R J Goldberg
Journal:  Eur Heart J       Date:  2003-10       Impact factor: 29.983

8.  Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.

Authors:  Roxana Mehran; Alexandra J Lansky; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; S Chiu Wong; Eugenia Nikolsky; Louise Gambone; Lynn Vandertie; Helen Parise; George D Dangas; Gregg W Stone
Journal:  Lancet       Date:  2009-08-28       Impact factor: 79.321

9.  Critical Appraisal of Bivalirudin versus Heparin for Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Trials.

Authors:  Anthony A Bavry; Islam Y Elgendy; Ahmed Mahmoud; Manoj P Jadhav; Tianyao Huo
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  Bivalirudin versus unfractionated heparin: a meta-analysis of patients receiving percutaneous coronary intervention for acute coronary syndromes.

Authors:  Mohamed Farag; Diana A Gorog; Abhiram Prasad; Manivannan Srinivasan
Journal:  Open Heart       Date:  2015-10-01
View more
  1 in total

1.  Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.

Authors:  Cho Yeow Koh; Norrapat Shih; Christina Y C Yip; Aaron Wei Liang Li; Weiming Chen; Fathiah S Amran; Esther Jia En Leong; Janaki Krishnamoorthy Iyer; Grace Croft; Muhammad Ibrahim Bin Mazlan; Yen-Lin Chee; Eng-Soo Yap; Dougald M Monroe; Maureane Hoffman; Richard C Becker; Dominique P V de Kleijn; Vaishali Verma; Amita Gupta; Vijay K Chaudhary; A Mark Richards; R Manjunatha Kini; Mark Y Chan
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.